The blood-thinning medication rivaroxaban was safe and effective at preventing the formation of blood clots in deep veins or the lungs, known as venous thromboembolism (VTE), in people with adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome, according to a recent study. The study demonstrated that the treatment prevented both new and recurrent…
News
Among adults with Cushing’s syndrome caused by tumors in both adrenal glands, surgery to remove the tumors led to the best cortisol control and the most favorable outcomes, according to a large international study. However, the risk of death and the rates of cardiovascular events were similar across different treatment…
A common diagnostic test for Cushing’s disease can fail to detect the condition in nearly 10% of patients, according to new research that suggests these “atypical” results may signal a more aggressive form of the disorder. The study found that patients who respond unusually to the test are significantly…
Weak bones and fragility fractures are highly prevalent among people with Cushing’s syndrome, a risk that persists even after achieving disease remission, according to a medical records analysis. Despite these findings, less than half of this patient population had their bone health properly assessed and/or managed, the data showed. “These…
Surgery is usually successful for bringing Cushing’s disease into remission, and most patients do not experience any problems — but nonetheless, serious and even fatal complications are possible, and surgery isn’t effective for all individuals with the disease. Those are the findings of a new study from the U.K.
Isturisa (osilodrostat) is now available in Canada for adults with Cushing’s disease who have persistent or recurrent high cortisol after pituitary surgery and/or pituitary irradiation, or who can’t have pituitary surgery, according to Recordati Rare Diseases Canada. The oral medication is approved in the U.S. and the European…
The corticotropin-releasing hormone (CRH) stimulation test is a reliable tool for diagnosing Cushing’s disease, according to a recent study. Results show that its accuracy is comparable to that of bilateral inferior petrosal sinus sampling (BIPSS), the gold standard but invasive method, in distinguishing Cushing’s disease from ectopic Cushing’s syndrome.
A woman with type 1 diabetes was diagnosed with Cushing’s disease after her daily insulin needs rose sharply and no longer controlled her blood sugar levels, a case study reports. “This case underscores the importance of regular review of automated insulin delivery data and consideration of [hormonal] causes of…
A diagnostic test using an artificial form of the naturally occurring hormone desmopressin could be a good alternative to the standard test used to diagnose Cushing’s disease in children and adolescents, according to a study. Researchers found that the accuracy of the desmopressin stimulation test (DDAVP) was comparable to…
Although acinic cell carcinoma — a cancer of the glands that produce saliva — is usually considered low risk, it can behave aggressively and cause Cushing’s syndrome, according to researchers who described such a case involving a 58-year-old man in Turkey. They added that if not recognized and treated…
Recent Posts
- Blood thinner rivaroxaban prevents clots in ACTH-dependent Cushing’s
- Surgery offers best cortisol control for adrenal Cushing’s syndrome
- Turning negatives into positives keeps me out of the ‘why me’ pit
- Common Cushing’s test may miss aggressive tumors in some patients
- Weak bones, fractures prevalent in Cushing’s syndrome: Analysis
- We’re preparing to finally bring our newborn daughter home
- Surgery brings Cushing’s remission to 60% of patients over 20 years: Study
- New Cushing’s disease treatment option reaches Canada with Isturisa
- I’m trying to be more honest about how medical trauma affects me
- CRH test may replace invasive method in diagnosing Cushing’s disease: Study